Potential Contribution of Preoperative Neoadjuvant Concurrent Chemoradiation Therapy on Margin-Negative Resection in Borderline Resectable Pancreatic Cancer

被引：0
|
作者：
Chang Moo Kang
Yong Eun Chung
Jeong Youp Park
Jin Sil Sung
Ho Kyoung Hwang
Hye Jin Choi
Hyunki Kim
Si Young Song
Woo Jung Lee
机构：
[1] Yonsei University College of Medicine,Division of Hepatobiliary and Pancreas, Department of Surgery
[2] Yonsei University College of Medicine,Division of Gastroenterology
[3] Yonsei University College of Medicine,Department of Internal Medicine
[4] Yonsei University College of Medicine,Department of Radiologic Oncology
[5] Yonsei University College of Medicine,Department of Radiology
[6] Yonsei University College of Medicine,Division of Medical Oncology
[7] Yonsei University College of Medicine,Department of Pathology
[8] Yonsei University Health System,Pancreaticobiliary Cancer Clinic, Institute of Gastroenterology
[9] Young Yonsei Panceatic Tumor Study Group,undefined
来源：
Journal of Gastrointestinal Surgery | 2012年 / 16卷
关键词：
Neoadjuvant; Chemoradiation; Pancreatic cancer; Borderline resectable;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：509 / 517
页数：8
相关论文
共 50 条
  • [41] Neoadjuvant GTX Chemotherapy and IMRT-Based Chemoradiation for Borderline Resectable Pancreatic Cancer
    Patel, Manish
    Hoffe, Sarah
    Malafa, Mokenge
    Hodul, Pamela
    Klapman, Jason
    Centeno, Barbara
    Kim, Jongphil
    Helm, James
    Valone, Tiffany
    Springett, Gregory
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (02) : 155 - 161
  • [42] Local Control in Resectable and Borderline Resectable Pancreatic Cancer (PCa) Treated With Preoperative Chemoradiation or Chemotherapy Alone
    Kharofa, J. R.
    Kelly, T.
    George, B.
    Tsai, S.
    Ritch, P.
    Christians, K.
    Evans, D.
    Erickson, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S189 - S189
  • [43] CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysis
    Park, Sohee
    Jang, Jong Keon
    Byun, Jae Ho
    Kim, Jin Hee
    Lee, Seung Soo
    Kim, Hyoung Jung
    Hong, Seung Baek
    Park, Seong Ho
    EUROPEAN RADIOLOGY, 2021, 31 (05) : 3383 - 3393
  • [44] Risk Factors Associated With Early Recurrence of Borderline Resectable Pancreatic Ductal Adenocarcinoma After Neoadjuvant Chemoradiation Therapy and Curative Resection
    Tsuchiya, Nobuhiro
    Matsuyama, Ryusei
    Murakami, Takashi
    Yabushita, Yasuhiro
    Sawada, Yu
    Kumamoto, Takafumi
    Endo, Itaru
    ANTICANCER RESEARCH, 2019, 39 (08) : 4431 - 4440
  • [45] Pathologic tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer
    June S Peng
    Jane Wey
    Sricharan Chalikonda
    Daniela S Allende
    R Matthew Walsh
    Gareth Morris-Stiff
    Hepatobiliary&PancreaticDiseasesInternational, 2019, 18 (04) : 373 - 378
  • [46] Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
    Danko Mikulic
    Anna Mrzljak
    World Journal of Clinical Cases, 2021, 9 (20) : 5398 - 5407
  • [47] Pathologic tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer
    Peng, June S.
    Wey, Jane
    Chalikonda, Sricharan
    Allende, Daniela S.
    Walsh, R. Matthew
    Morris-Stiff, Gareth
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (04) : 373 - 378
  • [48] Pathological tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer
    Stefan Heinrich
    Hepatobiliary&PancreaticDiseasesInternational, 2019, 18 (04) : 305 - 306
  • [49] Pathological tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer
    Heinrich, Stefan
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (04) : 305 - 306
  • [50] Toxicity associated with neoadjuvant therapy for borderline resectable pancreatic cancer (BRPC).
    Beg, M. S.
    Olowokure, O. O.
    Ali, S.
    Ahmad, S. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345